Loading company
Strata Critical Medical, Inc. (SRTA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $197.1 million | $146.8 million | +34.3% | 10-K 2026-03-03 · proof |
| Gross profit | $41.1 million | $29.6 million | +39% | 10-K 2026-03-03 · proof |
| Operating income | -$22.4 million | -$22.5 million | 10-K 2026-03-03 · proof | |
| Net income | $41.3 million | -$27.3 million | 10-K 2026-03-03 · proof | |
| Cash from operating activities | -$48.9 million | -$2.5 million | 10-K 2026-03-03 · proof | |
| Free cash flow | -$58.5 million | -$33.4 million | 10-K 2026-03-03 · proof | |
| Total assets | $325.5 million | $256.7 million | +26.8% | 10-K 2026-03-03 · proof |
| Total liabilities | $46.4 million | $34.7 million | +33.6% | 10-K 2026-03-03 · proof |
| Cash and cash equivalents | $31 million | $18.4 million | +68.5% | 10-K 2026-03-03 · proof |
- What was Strata Critical Medical, Inc. (SRTA)'s revenue in fiscal 2025?
- Strata Critical Medical, Inc. (SRTA) reported revenue of $197.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $146.8 million the year before (+34.3%). Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What was Strata Critical Medical, Inc. (SRTA)'s gross profit in fiscal 2025?
- Strata Critical Medical, Inc. (SRTA) reported gross profit of $41.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $29.6 million the year before (+39%). Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What was Strata Critical Medical, Inc. (SRTA)'s operating income in fiscal 2025?
- Strata Critical Medical, Inc. (SRTA) reported operating income of -$22.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$22.5 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What was Strata Critical Medical, Inc. (SRTA)'s net income in fiscal 2025?
- Strata Critical Medical, Inc. (SRTA) reported net income of $41.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$27.3 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What was Strata Critical Medical, Inc. (SRTA)'s cash from operating activities in fiscal 2025?
- Strata Critical Medical, Inc. (SRTA) reported cash from operating activities of -$48.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What was Strata Critical Medical, Inc. (SRTA)'s free cash flow in fiscal 2025?
- Strata Critical Medical, Inc. (SRTA) reported free cash flow of -$58.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$33.4 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What are Strata Critical Medical, Inc. (SRTA)'s total assets?
- As of Dec 31, 2025, Strata Critical Medical, Inc. (SRTA) reported total assets of $325.5 million, against $256.7 million a year earlier (+26.8%). Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What are Strata Critical Medical, Inc. (SRTA)'s total liabilities?
- As of Dec 31, 2025, Strata Critical Medical, Inc. (SRTA) reported total liabilities of $46.4 million, against $34.7 million a year earlier (+33.6%). Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
- What are Strata Critical Medical, Inc. (SRTA)'s cash and cash equivalents?
- As of Dec 31, 2025, Strata Critical Medical, Inc. (SRTA) reported cash and cash equivalents of $31 million, against $18.4 million a year earlier (+68.5%). Source: the 10-K filed with the SEC on Mar 3, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:SRTA&period_type=annual&limit=5"Information only, not investment advice.